Zenas BioPharma, Inc. (ZBIO) Reports Q1 Loss of $1.46
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections, more earnings
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts ZBIO Hot Sheet
Join SI Premium – FREE
Zenas BioPharma, Inc. (NASDAQ: ZBIO) reported Q1 EPS of ($1.46).
For earnings history and earnings-related data on Zenas BioPharma, Inc. (ZBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ExxonMobil shares drop as crude oil prices tumble
- Oppenheimer: 'We see at compelling entry point in LXEO stock at current levels'
- AT&T and AST SpaceMobile complete ground-to-satellite network handoff
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
